Introduction
============

Malaria parasites invade host erythrocytes via interaction between merozoite surface ligands and erythrocyte receptors \[[@B1],[@B2]\]. In *Plasmodium falciparum*, the erythrocyte binding antigen-175 (EBA-175) is one of the most important ligands mediating erythrocyte invasion by sialic acid dependent binding to glycophorin A \[[@B3],[@B4]\]. The 175 kDa protein is located in micronemes at the apical end of the merozoite \[[@B5]\]. Together with the Duffy-binding protein of *Plasmodium vivax*(PvDBP), EBA-175 belongs to a family of parasite adhesion molecules, the Duffy-binding-like erythrocyte-binding proteins (DBL-EBP) \[[@B6]\]. This protein family is characterized by a N-terminal signal peptide, cystein-rich Duffy-binding-like (DBL) domains, a carboxyl cysteine-rich region (c-cys), a transmembrane domain and a short cytoplasmatic tail. Encoding genes are members of the erythrocyte-binding-like (*ebl*) gene family. The e*ba-175*gene is located on chromosome 7 and consists of four exons \[[@B7],[@B8]\]. A large exon 1 is divided into regions I-VI and codes for a tandem array of two DBL domains in region II (Fl and F2) forming the putative ligand site as well as the c-cys domain, region VI. Both domains have numerous conserved cystein and hydrophobic amino acid residues supporting their functional relevance. They are separated by highly divergent dimorphic segments in region III \[[@B9]\]. This dimorphism is characterized by an insertion of either a 342 bp segment in FCR-3 strains (F-segment) or a 423 bp segment in CAMP strains (C-segment) \[[@B7],[@B10]\]. Both segments share little homology and are located at slightly different positions with the F-segment being 273 bp upstream of the C-segment. These two variants are conserved in all strains isolated so far and since *Plasmodium*merozoites are haploid either one or the other, but never both or neither segment is present in one individual parasite clone \[[@B10]\]. The functional relevance of the F-/C-segment dimorphism remains unknown. Human IgG antibodies recognize epitopes on the dimorphic F- and C-segments but are not associated with protection from clinical malaria in The Gambia \[[@B11]\]. Population genetic analysis showed a C-segment allele frequency of 73% in *eba-175*of *P. falciparum*in a Sudanese population whereas more than 70% of isolates from The Gambia, Nigeria, Cameroon, Gabon, Tanzania and South Africa carried the F-segment \[[@B12],[@B13]\].

The two variants of the *eba-175*dimorphism are evolutionarily conserved suggesting functional relevance. F- and C-segment frequencies vary in different ethnicities and geographic regions. It is, therefore, hypothesized that this dimorphism may influence clinical disease and outcome.

Methods
=======

Study area and parasites
------------------------

Samples were collected between August and November 2002 in Tamale and its vicinity, Northern Region, Ghana. Climate and vegetation are savannah-type. Malaria transmission is perennial but highly seasonal and infection rates are consistent with a hyperendemic malaria situtation (Mockenhaupt et al., unpublished data). Blood samples and clinical data were obtained from 290 children (aged 6 months to 9 years) with severe falciparum malaria (SM) according to the current WHO definition \[[@B14]\]. One sample was lost for genetic analysis. The clinical and parasitological characteristics of these children are described in detail elsewhere \[[@B15]\]. For each patient with SM, one age- and sex-matched asymptomatic but parasitaemic control was randomly selected from a survey representative for Tamale and the surrounding six districts. For that purpose, 30 communities and census units were recruited following a two-stage cluster sampling strategy with probability proportional to population size. Within each unit, ≥70 children aged 6 months to 9 years were randomly selected, clinical examinations were performed and venous blood samples were taken. Parasites were counted per ≥200 white blood cells on Giemsa-stained thick blood films and *P. falciparum*was substantiated by specific PCR assays \[[@B16]\].

DNA extraction and genotyping
-----------------------------

Blood was stabilized (AS1, Qiagen, Hilden, Germany), stored at 4°C and DNA was extracted by commercial kits (QIAmp blood kit, Qiagen, Hilden, Germany). Genotyping of the *eba*dimorphism was performed by nested PCR using primers EBA1 5\'-CAAGAAGCAGTTCCTGAGGAA-3\' (forward) and EBA2 5\'-TCTCAACATTCATATTAACAATTC-3\' (reverse) for the first amplification and EBA3 5\'-GAGGAAAACACTGAAATAGCACAC-3\' (forward) and EBA4 5\'-CAATTCCTCC-AGACTGTTGAACAT-3\' (reverse) for the second amplification \[[@B17]\]. The following mixture was used for 20 μl reaction volume \[[@B18]\]: 4 μl (50--200 ng) of DNA-template for the first amplification and 2 μl PCR-product for the nested PCR; 1 μl of each primer (l00 μM), 1 U HotStarTaq Polymerase (Qiagen^®^, USA); 1x PCR-Buffer, 1,5 mM magnesium chloride; and 200 μM dNTP. PCR was performed on T3 Thermocylcer (Biometra^®^, Germany) using the following conditions: Initial 5-min denaturation at 94°C followed by 29 cycles with 1-min at 94°C, 1-min at 56°C and 2-min 72°C and a 3-min final extension at 72°C. Amplicons were separated on 1.5% ethidiumbromide stained agarose gels and visualized using UV-translumination. A single band of 795 or 714 bp identified infection with parasites containing the F- or C-segment, respectively. Samples showing both bands reflected mixed infection with a minimum of two different clones.

Statistical analysis
--------------------

Geometric mean parasite density (GMPD) and 95% confidence intervals (95% CI) were calculated after log~10~transformation. Genotype frequencies were compared between case and control groups using Pearson Chi-Square test and Fisher\'s exact test as applicable. Subgroup analysis of the risk of individual symptoms was performed by conditional logistic regression models. Associations between genotypes and fatal outcome in severe malaria cases were corrected for known predictors of mortality (impaired consciousness, circulatory collapse, hypoglycaemia and malnutrition \[[@B15]\]) by multiple logistic regression analysis. A *P*-value \< .05 was considered as statistically significant.

Results
=======

The median age of the 289 children with severe malaria (154 girls, 135 boys) was 24 months (range 6--102). Mean rectal temperature (±SD) was 38.6°C (±1.1). GMPD was 30,200/μL (95% CI, 22,474--40,581) and hyperparasitaemia (\>250,000/μL) was present in 64 children (22%). The GMPD of parasitaemic controls was 1,738/μL (95% CI, 1,387--2,178). Cases exhibited the following symptoms defining severe malaria (WHO 2000): severe anemia (55%), prostration (34%), respiratory distress (23%), multiple convulsions (20%), impaired consciousness (19%), jaundice (12%), circulatory collapse (3%), and haemoglobinuria (3%). Case fatality rate was 11% (32/284). For five children, no data on outcome were available since they absconded during hospitalization.

In children with severe malaria, the F- and C-segment were present in 70% (201/289) and 19% (55/289), respectively (see Table [1](#T1){ref-type="table"}). Both segments were found in 11% (33/289) representing mixed infections. In the parasitaemic controls, the prevalences for the F- and C-segment were 61% (176/289) and 17% (49/289), respectively. Mixed infections were significantly less frequent in severe cases than in parasitaemic controls (11% (33/289) versus 22% (64/289); OR .5, \[95% CI .3--.7\], *P*= .003; F-segment used as reference). Matched pair analysis revealed no significant associations of the C- or F-segment with individual symptoms and conditions of SM (Table [1](#T1){ref-type="table"}). However, for all symptoms and conditions of SM except for haemoglobinuria, the C-segment was more common in severe cases while mixed infections occured more often in respective parasitaemic controls (not significant).

###### 

Matched pair analysis of children with severe malaria and asymptomatic parasitaemic controls: risk of symptoms and conditions of severe malaria

  Condition/Symptom                 Dimorphism     Severe malaria   Parasitaemic controls   OR \[95% CI\] *P*value (F-segment as reference)
  --------------------------------- -------------- ---------------- ----------------------- -------------------------------------------------
  All (n = 289)                     F-segment      201 (70)         176 (61)                
                                    F-/C-segment   33 (11)          64 (22)                 .5 \[.3--.7\] *.003*
                                    C-segment      55 (19)          49 (17)                 1.0 \[.6--1.7\] *1*
  Severe anaemia (n = 159)          F-segment      114 (72)         95 (60)                 
                                    F-/C-segment   18 (11)          37 (23)                 .4 \[.2--.8\] *.02*
                                    C-segment      27 (17)          26 (16)                 .9 \[.4--1.8\] *.9*
  Prostration (n = 97)              F-segment      67 (69)          55 (57)                 
                                    F-/C-segment   10 (10)          23 (24)                 .4 \[.1--1.0\] *.06*
                                    C-segment      20 (21)          18 (19)                 .8 \[.3--2.0\]. *.8*
  Respiratory Distress (n = 66)     F-segment      40 (61)          47 (71)                 
                                    F-/C-segment   9 (14)           10 (15)                 1.2 \[.4--3.7\] *1*
                                    C-segment      17 (26)          9 (14)                  2.0 \[.8--7.7\] *.2*
  Multiple Convulsions (n = 59)     F-segment      40 (68)          36 (61)                 
                                    F-/C-segment   6 (10)           15 (25)                 .4 \[.1--1.1\] *.1*
                                    C-segment      13 (22)          8 (14)                  2.0 \[.6--6.3\] *.4*
  Impaired Consciousness (n = 56)   F-segment      36 (64)          39 (70)                 
                                    F-/C-segment   8 (14)           9 (16)                  1 \[.3--3.6\] *1*
                                    C-segment      12 (21)          8 (14)                  1.6 \[.5--4.6\] *.6*
  Jaundice (n = 34)                 F-segment      23 (68)          21 (62)                 
                                    F-/C-segment   3 (9)            6 (18)                  .5 \[.04--2.5\] *.7*
                                    C-segment      8 (24)           7 (21)                  1 \[.3--3.6\] *1*
  Circulatory collapse (n = 10)     F-segment      6 (60)           8 (80)                  
                                    F-/C-segment   0 (0)            1 (10)                  \-
                                    C-segment      4 (40)           1 (10)                  3.0 \[.4--3.0\] *.6*
  Haemoglobinuria (n = 8)           F-segment      6 (75)           5 (63)                  
                                    F-/C-segment   0 (0)            1 (13)                  \-
                                    C-segment      2 (25)           2 (25)                  .5 \[0--4.9\] *1*
  Hyperparasitaemia (n = 64)        F-segment      43 (67)          47 (73)                 
                                    F-/C-segment   6 (9)            10 (16)                 .4 \[.1--1.6\] *.3*
                                    C-segment      15 (23)          7 (11)                  3\. 7 \[1.1--13.1\] *.06*
  Fatal outcome (n = 32)            F-segment      15 (47)          18 (56)                 
                                    F-/C-segment   4 (13)           7 (22)                  .5 \[.04--2.5\] *.7*
                                    C-segment      13 (41)          6 (19)                  4.0 \[.9--19.4\] *.1*

A trend towards a higher risk of dying of severe malaria was found in children with the C-segment in matched pair analysis (OR 4.0, \[95% CI .9--19.4\], *P*= .1; Table [1](#T1){ref-type="table"}). Associations of the *eba-175*dimorphism with symptoms, conditions, and outcome within the group of severe malaria cases were re-tested (Figure [1](#F1){ref-type="fig"}). The C-segment was significantly associated with fatal outcome (case fatality rates: F-segment: 8%, F-/C-segment: 13%, C-segment: 24%; \_^2^~trend~= 11.3, *P*= .0008). Logistic regression analysis adjusting for known predictors of death in these children \[[@B15]\] confirmed a six-fold increased risk of fatal outcome in patients infected with C-segment parasites as compared to F-segment parasites (OR 5.6, \[95% CI 1.8--17.1\], *P*\< .003; other predictors were: impaired consciousness, OR, 9.3; 95% CI, 3.4--25.9; *P*\< .0001; circulatory collapse, OR, 35.9; 95% CI, 4.5--290; *P*= .0008; hypoglycemia, OR, 3.7; 95% CI, 1.3--10.3; *P*= .01; malnutrition, OR, 95% CI, 2.5; 1.0--6.3; *P*= .06).

![*eba-175*dimorphism (F-segment, F-/C-mixed infection, C-segment): Percentage (absolute numbers) of severe malaria cases with respective symptoms, conditions, and outcome.](1475-2875-3-11-1){#F1}

Discussion
==========

This study aimed at evaluating the frequencies of a dimorphic allele segment in the gene encoding the erythrocyte binding antigen-175 on *P. falciparum*merozoites in children with severe malaria in northern Ghana. Second, associations of the *eba-175*dimorphism with symptoms, conditions, and outcome of severe disease were assessed in a case-control analysis.

In 289 Ghanaian children with severe malaria, the F-segment predominated (70%). C-segment and mixed infections were present in 19% and 11%, respectively. These findings are consistent with recently published data from West Africa \[[@B13]\].

In the case-control analysis, mixed infections were significantly more common in controls than in cases. This is in accordance with findings from other areas with high transmission \[[@B19],[@B20]\] and is considered to indicate acquired immunity \[[@B21]\]. However, the presence of either the F- or the C-segment alone does not exclude the possibility of infection with different strains and, therefore, limits validity of this finding. The overall distribution of the F- and C-alleles did not differ significantly between groups arguing against a role for the *eba*dimorphism in mediating severe malaria *per se*. This is consistent with the finding in the Gambia that antibodies against the dimorphism do not protect against clinical malaria \[[@B11]\]. Yet, within the group of children with severe malaria, fatal outcome was significantly associated with the C-segment (Figure [1](#F1){ref-type="fig"}). These findings suggest that the C-segment of the *eba-175*dimorphism on *P. falciparum merozoites*is associated with fatality in severe malaria rather than promoting disease progression from asymptomatic parasitaemia towards severe disease. A longitudinal study is needed to confirm this.

Unlike in West Africa, in a Sudanese population the C-segment was most frequent \[[@B13]\]. This part of Africa represents an ethnically distinct region with lower malaria endemicity. In a study conducted in Laos, the dimorphism was unequally distributed in distinct ethnic minorities \[[@B18]\]. Random shifts in parasite allele frequencies in different geographic regions can serve as an explanation. Also, susceptibility to infection and disease severity vary in different regions as does genetic variability in host populations. On the other hand, not only genetic differences in the host but also in the parasite may influence disease severity and outcome. Although the functional mechanism of the *eba-175*dimorphism regarding disease severity remains unclear one might postulate that this dimorphism offers alternative ways of erythrocyte invasion to the parasite and therefore allows more rapid replication. Since the *eba-175*dimorphism appears not to be involved in the binding to neuraminidase- or trypsin-sensitive erythrocyte receptors \[[@B22]\] it may recognize other, as yet unknown, receptors. This explanation is supported by the finding that the C-segment was associated at borderline statistical significance with hyperparasitaemia (OR 3.7 \[1.1--13.1\] *P*= .06. see Table [1](#T1){ref-type="table"}).

In conclusion, the C-segment of the *eba-175*allelic dimorphism on *P. falciparum*merozites is not associated with severe malaria *per se*but confers a higher risk of fatal disease in northern Ghana. These findings may contribute to the development of a diagnostic tool predicting disease outcome in children. Further studies are necessary to reveal its functional relevance.
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